Contract A207_PO-0445505

The University of Virginia awarded contract A207_PO-0445505 to Life Technologies Corporation on August 1, 2026, for the procurement of pharmaceutical-grade materials. The contract encompasses the delivery of Actinomycin D, a biochemical reagent commonly utilized in research and laboratory applications. The prime contractor is obligated to supply 161 units of Actinomycin D at 10 milligrams per unit, with a unit price of $1.00 per unit, resulting in a cumulative contract value of $161.

The contract represents a purchase order arrangement between the University of Virginia and Life Technologies Corporation for delivery to the purchasing institution. The line item specification indicates that Actinomycin D will be delivered to the buyer for research or institutional use. As a research-grade chemical procurement, this contract supports the laboratory and scientific operations of the University of Virginia. The modest contract value and single line item structure are consistent with a routine supply purchase order for academic research purposes.